| Type | MGI:General | Description | streptozotocin (STZ)-treated mice subjected to myocardial infarction (MI) exhibit resistance to increased mortality with increased resting heart rate, reduced episodes of very low heart rate, improved activity-related heart rate increases, improved intrinsic sinus node function, reduced apoptosis in the sinoatrial node and reduced fibrosis compared with similarly treated wild-type mice |
